Loading...
Loading...
India's fluconazole imports from CHINA total $712 across 1 shipments from 1 foreign suppliers. JAMP PHARMA CORPORATION leads with $712 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ECRON ACUNOVA LIMITED. This corridor reflects India's pharmaceutical import demand for fluconazole — a concentrated sourcing relationship with select suppliers from CHINA.

JAMP PHARMA CORPORATION is the leading Fluconazole supplier from CHINA to India, with import value of $712 across 1 shipments. The top 5 suppliers — JAMP PHARMA CORPORATION — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | JAMP PHARMA CORPORATION | $712 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ECRON ACUNOVA LIMITED | $712 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Fluconazole suppliers from CHINA to India include JAMP PHARMA CORPORATION. The leading supplier is JAMP PHARMA CORPORATION with import value of $712 USD across 1 shipments. India imported Fluconazole worth $712 USD from CHINA in total across 1 shipments.
India imported Fluconazole worth $712 USD from CHINA across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Fluconazole sourced from CHINA include ECRON ACUNOVA LIMITED. The largest buyer is ECRON ACUNOVA LIMITED with $712 in imports across 1 shipments.
The total value of Fluconazole imports from CHINA to India is $712 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists